Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

NCT00373048 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: mefloquine
DRUG: placebo

Sponsor

Institute of Tropical Medicine, Belgium